GSK-356278

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGSK-356278
Drug Alias NameGSK-356278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsDepressive DisorderAnxiety DisordersHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDepressive DisorderAnxiety DisordersHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A